KEGG   PATHWAY: mcc04012Help
Entry
mcc04012                    Pathway                                

Name
ErbB signaling pathway - Macaca mulatta (rhesus monkey)
Description
The ErbB family of receptor tyrosine kinases (RTKs) couples binding of extracellular growth factor ligands to intracellular signaling pathways regulating diverse biologic responses, including proliferation, differentiation, cell motility, and survival. Ligand binding to the four closely related members of this RTK family -epidermal growth factor receptor (EGFR, also known as ErbB-1 or HER1), ErbB-2 (HER2), ErbB-3 (HER3), and ErbB-4 (HER4)-induces the formation of receptor homo- and heterodimers and the activation of the intrinsic kinase domain, resulting in phosphorylation on specific tyrosine residues (pY) within the cytoplasmic tail. Signaling effectors containing binding pockets for pY-containing peptides are recruited to activated receptors and induce the various signaling pathways. The Shc- and/or Grb2-activated mitogen-activated protein kinase (MAPK) pathway is a common target downstream of all ErbB receptors. Similarly, the phosphatidylinositol-3-kinase (PI-3K) pathway is directly or indirectly activated by most ErbBs. Several cytoplasmic docking proteins appear to be recruited by specific ErbB receptors and less exploited by others. These include the adaptors Crk, Nck, the phospholipase C gamma (PLCgamma), the intracellular tyrosine kinase Src, or the Cbl E3 ubiquitin protein ligase.
Class
Environmental Information Processing; Signal transduction
BRITE hierarchy
Pathway map
ErbB signaling pathway
mcc04012

All organismsOrtholog table
Organism
Macaca mulatta (rhesus monkey) [GN:mcc]
Gene
698619  
EGF; epidermal growth factor [KO:K04357]
613031  
TGFA; transforming growth factor, alpha [KO:K08774]
702396  
AREGB; amphiregulin B [KO:K09782]
613027  
EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
697573  
ERBB2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) [KO:K05083] [EC:2.7.10.1]
697069  
PLCG1; phospholipase C, gamma 1 [KO:K01116] [EC:3.1.4.11]
714173  
PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) [KO:K05859] [EC:3.1.4.11]
705980  
CAMK2G; calcium/calmodulin-dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]
702504  
CAMK2D; calcium/calmodulin-dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]
706977  
calcium/calmodulin-dependent protein kinase type II subunit beta-like; K04515 calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:2.7.11.17] [KO:K04515] [EC:2.7.11.17]
701195  
PRKCB; protein kinase C, beta [KO:K02677] [EC:2.7.11.13]
720263  
PRKCG; protein kinase C, gamma [KO:K02677] [EC:2.7.11.13]
718412  
PRKCA; protein kinase C, alpha [KO:K02677] [EC:2.7.11.13]
713112  
CBLC; Cbl proto-oncogene, E3 ubiquitin protein ligase C [KO:K04707] [EC:6.3.2.19]
704311  
CBL; Cbl proto-oncogene, E3 ubiquitin protein ligase [KO:K04707] [EC:6.3.2.19]
703879  
e3 ubiquitin-protein ligase CBL-B-like; K04707 E3 ubiquitin-protein ligase CBL [EC:6.3.2.19] [KO:K04707] [EC:6.3.2.19]
574129  
STAT5A; signal transducer and activator of transcription 5A [KO:K11223]
709760  
STAT5B; signal transducer and activator of transcription 5B [KO:K11224]
701057  
SRC; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) [KO:K05704] [EC:2.7.10.2]
700634  
PTK2; PTK2 protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]
696584  
CRKL; v-crk sarcoma virus CT10 oncogene homolog (avian)-like [KO:K04438]
701185  
adapter molecule crk-like; K04438 proto-oncogene C-crk [KO:K04438]
722449  
ABL1; c-abl oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]
717037  
ABL2; v-abl Abelson murine leukemia viral oncogene homolog 2 [KO:K08887] [EC:2.7.10.2]
716807  
NCK1; NCK adaptor protein 1 [KO:K07365]
713287  
NCK2; NCK adaptor protein 2 [KO:K07365]
698585  
PAK1; p21 protein (Cdc42/Rac)-activated kinase 1 [KO:K04409] [EC:2.7.11.1]
710314  
PAK2; p21 protein (Cdc42/Rac)-activated kinase 2 [KO:K04410] [EC:2.7.11.1]
706217  
PAK3; p21 protein (Cdc42/Rac)-activated kinase 3 [KO:K05733] [EC:2.7.11.1]
696676  
PAK4; p21 protein (Cdc42/Rac)-activated kinase 4 [KO:K05734] [EC:2.7.11.1]
701589  
PAK6; p21 protein (Cdc42/Rac)-activated kinase 6 [KO:K05735] [EC:2.7.11.1]
719458  
PAK7; p21 protein (Cdc42/Rac)-activated kinase 7 [KO:K05736] [EC:2.7.11.1]
718155  
MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]
710077  
dual specificity mitogen-activated protein kinase kinase 7-like; K04431 mitogen-activated protein kinase kinase 7 [EC:2.7.12.2] [KO:K04431] [EC:2.7.12.2]
699736  
MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
711115  
MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
716452  
JUN; jun proto-oncogene [KO:K04448]
722713  
ELK1; ELK1, member of ETS oncogene family pseudogene [KO:K04375]
712610  
ELK1; ELK1, member of ETS oncogene family [KO:K04375]
702178  
BTC; betacellulin [KO:K09783]
695559  
HBEGF; heparin-binding EGF-like growth factor [KO:K08523]
702502  
EREG; epiregulin [KO:K09784]
711407  
ERBB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) [KO:K05084] [EC:2.7.10.1]
696275  
NRG1; neuregulin 1 [KO:K05455]
713584  
ERBB4; LOW QUALITY PROTEIN: receptor tyrosine-protein kinase erbB-4-like [KO:K05085] [EC:2.7.10.1]
574275  
SHC3; SHC (Src homology 2 domain containing) transforming protein 3 [KO:K06279]
718982  
SHC1; SHC (Src homology 2 domain containing) transforming protein 1 [KO:K06279]
714611  
SHC4; SHC (Src homology 2 domain containing) family, member 4 [KO:K06279]
721021  
SHC2; SHC (Src homology 2 domain containing) transforming protein 2 [KO:K06279]
702041  
growth factor receptor-bound protein 2-like; K04364 growth factor receptor-binding protein 2 [KO:K04364]
713777  
SOS1; son of sevenless homolog 1 (Drosophila) [KO:K03099]
705601  
SOS2; son of sevenless homolog 2 (Drosophila) [KO:K03099]
698830  
HRAS; v-Ha-ras Harvey rat sarcoma viral oncogene homolog [KO:K02833]
707977  
KRAS; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog [KO:K07827]
709089  
NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog [KO:K07828]
707169  
ARAF; v-raf murine sarcoma 3611 viral oncogene homolog [KO:K08845] [EC:2.7.11.1]
693554  
serine/threonine-protein kinase B-raf-like; K04365 B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1] [KO:K04365] [EC:2.7.11.1]
694725  
RAF1; v-raf-1 murine leukemia viral oncogene homolog 1 [KO:K04366] [EC:2.7.11.1]
710415  
MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
721821  
MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
698569  
MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
708938  
MAPK3; mitogen-activated protein kinase 3-like [KO:K04371] [EC:2.7.11.24]
694626  
MYC; v-myc myelocytomatosis viral oncogene homolog (avian) [KO:K04377]
700367  
GAB1; GRB2-associated binding protein 1 [KO:K09593]
699268  
NRG3; neuregulin 3 [KO:K05457]
707378  
NRG4; neuregulin 4 [KO:K05458]
698857  
PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma [KO:K00922] [EC:2.7.1.153]
716098  
PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
709959  
PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
707310  
PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma) [KO:K02649]
719367  
PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta) [KO:K02649]
722027  
PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5 [KO:K02649]
698996  
PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha) [KO:K02649]
714717  
AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) [KO:K04456] [EC:2.7.11.1]
697747  
AKT1; v-akt murine thymoma viral oncogene homolog 1 [KO:K04456] [EC:2.7.11.1]
700591  
AKT2; v-akt murine thymoma viral oncogene homolog 2 [KO:K04456] [EC:2.7.11.1]
721731  
RPS6KB2; ribosomal protein S6 kinase, 70kDa, polypeptide 2 [KO:K04688] [EC:2.7.11.1]
711979  
RPS6KB1; ribosomal protein S6 kinase, 70kDa, polypeptide 1 [KO:K04688] [EC:2.7.11.1]
703628  
EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]
717740  
BAD; BCL2-associated agonist of cell death [KO:K02158]
713114  
GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
719199  
CDKN1A; cyclin-dependent kinase inhibitor 1A (p21, Cip1) [KO:K06625]
Compound
C00076  
Calcium cation
C00165  
Diacylglycerol
C01245  
D-myo-Inositol 1,4,5-trisphosphate
C05981  
Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
Reference
  Authors
Yarden Y, Sliwkowski MX.
  Title
Untangling the ErbB signalling network.
  Journal
Nat Rev Mol Cell Biol 2:127-37 (2001)
Reference
  Authors
Citri A, Yarden Y.
  Title
EGF-ERBB signalling: towards the systems level.
  Journal
Nat Rev Mol Cell Biol 7:505-16 (2006)
Reference
  Authors
Scaltriti M, Baselga J.
  Title
The epidermal growth factor receptor pathway: a model for targeted therapy.
  Journal
Clin Cancer Res 12:5268-72 (2006)
Reference
  Authors
Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS.
  Title
Epidermal growth factor receptor (EGFR) signaling in cancer.
  Journal
Gene 366:2-16 (2006)
Reference
  Authors
Holbro T, Hynes NE.
  Title
ErbB receptors: directing key signaling networks throughout life.
  Journal
Annu Rev Pharmacol Toxicol 44:195-217 (2004)
Reference
  Authors
Liang J, Slingerland JM.
  Title
Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.
  Journal
Cell Cycle 2:339-45 (2003)
Reference
  Authors
Hynes NE, Lane HA.
  Title
ERBB receptors and cancer: the complexity of targeted inhibitors.
  Journal
Nat Rev Cancer 5:341-54 (2005)
Reference
  Authors
Oda K, Matsuoka Y, Funahashi A, Kitano H.
  Title
A comprehensive pathway map of epidermal growth factor receptor signaling.
  Journal
Mol Syst Biol 1:2005.0010 (2005)
Reference
  Authors
Schulze WX, Deng L, Mann M.
  Title
Phosphotyrosine interactome of the ErbB-receptor kinase family.
  Journal
Mol Syst Biol 1:2005.0008 (2005)
Reference
  Authors
Olayioye MA, Neve RM, Lane HA, Hynes NE.
  Title
The ErbB signaling network: receptor heterodimerization in development and cancer.
  Journal
EMBO J 19:3159-67 (2000)
Reference
PMID:9872057
  Authors
McCarty JH.
  Title
The Nck SH2/SH3 adaptor protein: a regulator of multiple intracellular signal transduction events.
  Journal
Bioessays 20:913-21 (1998)
Reference
  Authors
Clark DE, Williams CC, Duplessis TT, Moring KL, Notwick AR, Long W, Lane WS, Beuvink I, Hynes NE, Jones FE.
  Title
ERBB4/HER4 potentiates STAT5A transcriptional activity by regulating novel STAT5A serine phosphorylation events.
  Journal
J Biol Chem 280:24175-80 (2005)
Reference
  Authors
Muthuswamy SK, Gilman M, Brugge JS.
  Title
Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.
  Journal
Mol Cell Biol 19:6845-57 (1999)
Reference
PMID:9642287
  Authors
Hashimoto Y, Katayama H, Kiyokawa E, Ota S, Kurata T, Gotoh N, Otsuka N, Shibata M, Matsuda M.
  Title
Phosphorylation of CrkII adaptor protein at tyrosine 221 by epidermal growth factor receptor.
  Journal
J Biol Chem 273:17186-91 (1998)
KO pathway
 

DBGET integrated database retrieval system